What does a needle cost?

A data-driven guide to procurement pricing for hypodermic, safety-engineered, and specialty needles.

Needle pricing is deceptively simple on the surface but branches into multiple cost levers once you look at volume, safety features, and supplier channel. In the United States, needles can cost as little as 97 cents each , but institutional buyers see wide ranges depending on gauge, construction, regulatory class, and contract tier. Most hospital procurement officers negotiate unit costs between $0.08 and $0.35 per needle for standard hypodermic stock, while safety-engineered needles and syringes are more expensive than conventional non-safety needles . This article reflects currently available market data; MedSource will update pricing as institutional quote volumes accrue.

What the typical range is

Publicly listed retail and wholesale pricing shows:

BD PrecisionGlide™ hypodermic needle, 18G × 1-1/2", box of 100, retails at $9.18 — approximately $0.092 per needle.

20 Gauge × 1.5" needles, 100-pack, list around $11.52 — roughly $0.115 per needle.

22 Gauge × 1.5" needles, 100-pack, list around $11.52 — approximately $0.115 per needle.

These are list prices at major medical-supply retailers; actual institutional contract pricing is typically 25–45% lower due to GPO agreements, volume commitments, and direct-manufacturer relationships. High-volume hospitals moving 500,000+ needles annually often negotiate per-unit costs under $0.10 for standard gauges.

What pushes price up — features, certifications, support tier

Safety-engineered devices. Manufacturers generally charge more for safety products, when compared to traditional models and attribute the expense to cost of startup, low volume production, and more parts . Safety-engineered needles with retractable or shielded mechanisms command premiums of 20–40% over conventional designs. Examples include BD's Safety-Lok or Cardinal Health's Monoject Magellan line.

Gauge specialization. Smaller gauges (28–33G) and larger gauges (15–16G) cost slightly more than mid-range stock (20–25G) due to lower production volume.

Low dead-space (LDS) construction. LDS needles often cost slightly more than standard needles due to their specialized design . These reduce medication waste in high-cost vaccine and biologic programs.

Brand and manufacturer. Smiths Medical, Nipro, Popper & Sons, and Exel International are among the leading suppliers of hypodermic needles . Premium brands (BD, Terumo) carry 10–15% premiums over generics or regional manufacturers due to quality certifications (ISO 13606, FDA 510(k) clearances) and supply reliability.

Regulatory compliance tier. Needles meeting OSHA Bloodborne Pathogen Standard engineering controls requirements (documented sharps injury prevention features) carry higher baseline costs than non-compliant designs.

What pushes price down — refurbished, older generation, lease, GPO contracts

Group Purchasing Organization (GPO) contracts. Hospitals enrolled in programs like VHA, MedAssets, or Vizient negotiate institutional pricing 30–45% below retail list. These contracts often lock in pricing for 2–3 years, insulating buyers from commodity-price swings.

Volume tiers. Orders of 250,000+ needles per year qualify for steeper discounts. Community hospitals averaging 50,000 needles monthly may achieve $0.06–$0.08 per unit; large health systems or integrated procurement consortia reach $0.04–$0.06.

Older-generation designs. Needles without the latest safety-mechanism innovations (e.g., pre-2015 retractable designs) occasionally appear at surplus or closeout pricing, though regulatory mandates and staff familiarity with newer designs make inventory turnover predictable.

Direct manufacturer relationships. Facilities with long-standing contracts and commitment letters to specific manufacturers (e.g., BD, Terumo, Nipro) often receive volume discounts and priority allocation during supply shortages.

Commodity sourcing. According to global trade data, leading hypodermic needle suppliers include Terumo (Philippines) Corporation, Sol Millennium Medical, and Berpu Medical Technology . Procurement teams comparing imports can sometimes source sub-$0.05-per-unit needles from Asian suppliers, though lead times, quality verification, and regulatory compliance require 8–12 weeks.

Hidden costs — install, training, calibration, consumables, service contracts

Training and change management. Transitioning from standard to safety-engineered needles requires staff education on activation protocols. Informants spoke of "change fatigue" as a barrier to considering new safety-engineered needle technology or to the implementation of additional training opportunities . Budget 2–6 hours per unit of staff (nurses, phlebotomists, lab techs) at loaded labor rates.

Sharps disposal and waste management. Needles are regulated medical waste. Disposal container rentals, hazardous-waste pickup, and incineration compliance typically run $0.02–$0.05 per needle over its lifecycle. Facilities producing 500,000 needles annually may spend $10,000–$25,000 annually on sharps disposal alone.

Needlestick injury liability and testing. Depending on treatment, the cost of needlestick injuries is estimated to range from $71 to $5,000 . While injury costs belong in your occupational health budget, they underscore the ROI on safety-engineered devices—particularly in high-volume procedural settings.

Supply-chain redundancy. Hospitals maintain 2–4 months' inventory to buffer against supplier disruptions. For a facility using 500,000 needles annually, carrying inventory ties up $10,000–$20,000 in working capital.

Regulatory compliance documentation. Facilities subject to state needle-safety mandates or hospital accreditation standards (TJC, DNV) must maintain supplier certifications, material safety data sheets (MSDS), and usage logs. This administrative overhead, while not line-item cost, justifies vendor consolidation to reduce audit burden.

How to negotiate — concrete tactics

Request a spend analysis. Ask your current supplier for a 12-month consumption report broken down by gauge, length, and packaging. This baseline prevents you from overpaying for underutilized SKUs. Use the data to challenge usage patterns; many facilities stock 40+ needle configurations when 8–12 covers 90% of procedures.

Benchmark against GSA and state contract schedules. Federal supply schedules (GSA MAS) publish ceiling prices; many state Medicaid programs disclose negotiated rates. Use these as floor references. If your quote is 20%+ above published GSA pricing for identical products, supplier justification is warranted.

Consolidate to 2–3 suppliers maximum. Each supplier adds compliance, invoice reconciliation, and inventory-management overhead. Offering volume commitment (90% of annual spend) to one or two vendors typically unlocks 15–25% discounts vs. fractional orders across five suppliers.

Separate safety-engineered from standard stock. Some facilities incorrectly buy all needles as safety devices, inflating costs. Negotiate tiered pricing: standard needles for low-risk procedures (subcutaneous insulin injection, saline flush) at commodity rates; safety-engineered devices for blood draws, IV placement, and epidurals at premium rates justified by OSHA compliance.

Lock in 2–3 year pricing with escalation caps. Avoid annual renegotiations. Propose fixed pricing with a 2–3% annual escalation cap, indexed to industry inflation indices (CPI medical devices or PPI for medical supplies). This provides budget predictability and reduces supplier turnover.

Evaluate alternative gauges and LDS options. Some drug protocols work equally well with 23G vs. 21G needles, or standard vs. LDS construction. Pilot testing (500–1,000 units per variant) on a willing unit often identifies 10–15% cost savings without clinical compromise.

When the price feels off — red flags

Prices below $0.04 per unit on brand-name products. Legitimate manufacturers rarely discount branded hypodermic needles below $0.04 per unit at hospital volume. Pricing in this range suggests counterfeit stock, expired inventory, or products without FDA 510(k) clearance. Request Certificate of Conformance (CoC) and batch traceability.

Supplier unable to provide 510(k) documentation or ISO 13606 certification. All hypodermic needles sold in the U.S. market must carry FDA clearance or approval. Absence of documentation is a regulatory red flag and disqualifies the supplier.

Significant price variance (>30%) for identical gauge and length across suppliers. Competition in hypodermic needles is mature; wide discrepancies often signal differences in construction (material, sharpness, wall thickness) or supplier reputation. Request side-by-side product comparison and material specs.

No volume discount structure above 250,000 units annually. Suppliers claiming "we can't discount below list for large orders" lack manufacturing scale or commitment to your facility. Move to competitors.

Quotes that bundle unrelated consumables (syringes, alcohol pads, sharps containers) at inflated pricing. Negotiate categories separately. Bundled pricing often obscures overcharges on low-visibility items like sharps disposal. Request itemized invoicing and separate unit pricing for each SKU.

Supplier claims needles "cost the same whether safety-engineered or not." Safety-engineered needles are more expensive than conventional non-safety needles and syringes, and the initial adoption had significant cost implications for hospitals . Any vendor claiming price parity is either misrepresenting product specifications or pushing low-quality stock.

Sources

• Mordor Intelligence. Hypodermic Needles Market Size, Share & 2030 Growth Trends Report, July 2025.
• Fortune Business Insights. Needle Market Size, Share, Growth, Drivers & Trends, 2024–2034.
• OSHA. Needlestick Safety and Prevention Act & Bloodborne Pathogens Standard, 29 CFR 1910.1030, 2001.
• Cardinal Health. Safety-Engineered Sharps Devices: Product Specifications & OSHA Compliance, 2026.
• PMC/NIH. Barriers to the Adoption of Safety-Engineered Needles Following a Regulatory Standard, 2016.
• CIA Medical, Vitality Medical, Best Buy Medical Supplies. Retail & Wholesale Pricing Data, 2025–2026.

---

Note: This article reflects publicly verifiable pricing as of May 2026. Institutional GPO and direct-contract pricing varies by facility size, geographic region, and negotiation leverage. MedSource will update this guide quarterly as aggregate procurement quote data accumulates.